Trial intelligence / Profile preview

Booster Vaccination With Synflorix and Co-administered Vaccines

NCT00463437Phase 3Completed

Sponsor
GSK
Start
Apr 2007
Primary completion
Jan 2008
Modality
Split/Subunit Vaccines
Countries
3
01

Overview

A Phase 3 trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection, sponsored by GSK. Started Apr 2007; status: completed.

02

Drugs

10-valent pneumococcal conjugate vaccine
03

Conditions

pneumococcal infection

Beyond the preview

Go deeper on NCT00463437.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00463437.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call